Health Care & Life Sciences » Pharmaceuticals | Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Hebei Changshan Biochemical Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
115,218.10
134,317.20
156,673.90
178,315.30
202,312.40
132,211.60
Depreciation, Depletion & Amortization
17,420.30
27,896.70
31,889.10
36,922.90
42,118.50
45,549.20
Other Funds
34,781.80
-
31,927.50
703,001.60
40,982.30
116,193.90
Funds from Operations
147,808.80
158,129.10
220,125.60
246,167.60
274,784.70
297,146.10
Changes in Working Capital
163,053.20
269,218.00
258,264.80
72,151.10
112,300.60
4,182.70
Net Operating Cash Flow
15,244.40
111,088.80
38,139.10
174,016.60
162,484.10
292,963.40
Capital Expenditures
267,203.90
151,207.20
85,343.90
96,521.90
158,299.40
Sale of Fixed Assets & Businesses
7.80
15.00
45.00
62.50
58.70
Purchase/Sale of Investments
-
7,222.80
-
334,662.80
88,000.00
Net Investing Cash Flow
267,647.10
157,985.00
85,638.00
431,122.10
246,005.80
Cash Dividends Paid - Total
-
-
16,015.60
24,965.50
14,024.50
Issuance/Reduction of Debt, Net
39,300.00
236,200.00
90,159.40
79,845.20
191,381.10
Net Financing Cash Flow
4,518.20
236,200.00
42,216.30
598,191.00
136,374.30
Net Change in Cash
278,373.30
32,873.80
81,560.80
341,626.20
52,777.20
Free Cash Flow
282,448.30
262,296.00
123,483.00
77,494.70
4,184.60
Deferred Taxes & Investment Tax Credit
2,545.20
2,830.20
827.90
22.50
3,681.00
3,191.50
Other Sources
1,947.00
1,400.00
200.00
-
1,945.00
Exchange Rate Effect
-
-
-
540.80
75.40
Other Uses
2,398.00
970.00
539.10
-
1,710.00

About Hebei Changshan Biochemical Pharmaceutical Co.

View Profile
Address
North End of Yinchuan Avenue
Shijiazhuang Hebei 050800
China
Employees -
Website http://www.heparin.cn
Updated 07/08/2019
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. Its products include heparin raw materials, heparin sodium injection, enoxaparin sodium API, heparin sodium raw materials, low molecular weight heparin calcium drug, enoxaparin sodium injection, and low molecular weight heparin calcium injection. The company was founded on September 28, 2000 and is headquartered in Shijiazhuang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.